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ABSTRACT
This study was undertaken to evaluate the effect of Corchorus Olitorius (Molokhia) soup on
the oral absorption of ciprofloxacin from solid dosage forms in rabbits. A single dose of
ciprofloxacin tablet (125 mg) was administered to rabbits in a fasted state or with Molokhia soup.
Plasma ciprofloxacin concentrations were measured by high-performance liquid chromatography.
The results demonstrated a profound effect of Molokhia soup on the bioavailability of
ciprofloxacin compared to the fasted state. The intake of Molokhia soup reduced the rate and extent
of ciprofloxacin oral bioavailability. The geometric mean (Cmax and AUC) values of ciprofloxacin
were significantly lower under fed compared to the fasted states. Administration of ciprofloxacin
with Molokhia soup was associated with a delay in the time to reach peak concentration (Tmax) by
about half hour. Therefore, co-administration of Molokhia soup with ciprofloxacin may have a
potential negative effect on the release and oral absorption of Ciprofloxacin from tablets, This may
result in serious decrease in the efficacy of this antibiotic and potential bacterial resistance.
Keywords: Corchorus Olitorius, Ciprofloxacin, Absorption, Food Effect.

INTRODUCTION
Oral drug administration is the most
convenient route for drug delivery because of
its feasibility and safety. The oral bioavailability of drugs may be affected by presence
of food in the gastrointestinal tract. Food may
lead to alterations in the pharmacokinetics or
pharmacodynamics of the active pharmaceutical ingredients. Meals may increase or decrease or have no effect on the absorption of
drugs. Undesirable food effects may result in
sub-therapeutic levels of the drug and a high
risk of treatment failure (1).
The proposed theories explaining the
possible mechanisms behind undesirable
food effects include: Food induced changes
in the GI physiology (pH, motility, transient
times, and viscosity), chelation interactions
of the drug with food components, delayed

tablet disintegration and drug dissolution
rates under fed conditions (2-7).
Ciprofloxacin is a fluoroquinolone antibiotic which is effective against many grampositive and gram-negative bacteria. It is
commonly prescribed for the treatment of
urinary tract infections.The bactericidal action of this drug is due to its interference with
the DNA gyrase enzyme, which is involved
in the synthesis of bacterial DNA (8).
The literature data is conflicting regarding the assignment of ciprofloxacin to a specific Biopharmaceutic Classification System
(BCS) class. Some studies classified ciprofloxacin as BCS II/IV (9). Breda and coauthors characterized it as BCS II (10).On the
other hand, other studies considered it to lay
between class II and III since its solubility is
pH dependent, that is, its solubility is high at
low pH and low at basic pH (11).
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Pharmacokinetic studies on ciprofloxacin have been conducted in humans and
many animal species. Ciprofloxacin is well
absorbed after oral administration and has
good oral bioavailability (70% and 80%).
The serum half-life of ciprofloxacin is about
4-6 hour (hr), with the maximum plasma
concentration Cmax within Tmax 1 to 2 hr (1214).
A previously conducted study showed
that concomitant intake of food with ciprofloxacin has no significant effect on the extent
of drug absorption, except a delay in the rate
of its absorption represented by prolonged
Tmax (15). However, the oral bioavailability
of Ciprofloxacin was significantly reduced
with the intake of dairy products due to chelation interaction between the drug and the
di-and trivalent cations (16, 17).
Corchorus Olitorius is a member of the
Tiliaceae plant family that is commonly cultivated in Egyptian and Middle Eastern countries. It is also known as mulukhiya,
molohiya, mloukhiya and jute. It has many
therapeutic effects like diuretic, antipyretic,
analgesic, antimicrobial, antitumor and antioxidants activity (18). Furthermore, C.
Olitorius is a good source of vitamins (C, E,
K, B6, A) and minerals such as potassium,
iron, calcium, magnesium, phosphorous, and
selenium. The leaves of this plant are rich in
mucilage polysaccharides and hydrocolloids
(19). C. Olitorius leaves are prepared as a
viscous soup, and is considered as one of the
most popular and delicious dishes in the
Mediterranean, Arab and other worldwide
regions.
The effect of Molokhia soup on the
pharmacokinetics of ciprofloxacin has not
been studied before. The aim of this study is
to evaluate the effect of Molokhia soup on
the bioavailability of a single dose of ciprofloxacin in rabbit models and to provide a mechanical explanation of food effects.
MATERIALS AND METHODS
Materials
Ciprofloxacin hydrochloride immediate
release tablets (Ciprocare) ® 250 mg
(Pharmacare, Palestine) were used in this
study. Ciprofloxacin hydrochloride powder

(purity 99%) was donated kindly by
(Pharmacare, Palestine). High Performance
Liquid Chromatography (HPLC) grade solvents of acetonitrile (ACN), triethylamine,
phosphoric acid (85%), were purchased from
Sigma-Aldrich. Molokhia leaves were obtained from local market.
Molokai soup was prepared by cutting
the fresh leaves of C. olitorius (50 g) and
mixing thoroughly with 1 L water using
mixer and heating until boiling.
Animals
Eight local breads rabbits, weighing between (3-4 kg), were included in this study.
The animals were kept indoors and fed with
fresh green fodder. Water was provided
freely as much they required. The experimental protocol was done under internationally accepted animal welfare guidelines.
In vivo bioavailability
Protocol of the Study: The effects of
Molokhia soup on the pharmacokinetics of
Ciprofloxacin was studied after administration of an oral single dose in healthy rabbits.
Study design: In a parallel design, eight
rabbits were randomly divided in to two
groups (n=4). They had not been previously
fed any food containing antibiotics especially
ciprofloxacin and they were in fasting state
overnight before drug administration. All
animals were exposed to similar conditions.
Drug administration: Each rabbit in the
first group was fed with 5 mL of Molokhia
soup in the morning, whereas the rabbits in
the second group were in a fasting state at the
time of drug administration. Each rabbit received a single oral dose of 125 mg of the
drug. Ciprocare® 250 mg tablets in its solid
dosage form were broken in half and administered orally to the eight rabbits. The drug
was administered within 5 min after soup
intake.
Blood sampling: About 2 ml blood
samples were withdrawn from the rabbits
ears in heparinized glass tubes using sterilized plastic syringes at times: 0 (pre-dose),
0.25, 0.5, 0.75, 1, 1.5,2, 3, 4 and 10 hrs after
the drug administration. The blood samples
were immediately centrifuged using (Hettich
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centrifuge universal 320, United Kingdom) at
3000 rpm for 10 min to separate the plasma,
which were stored at -20°C until analyzed.
Sample preparation: A liquid-phase extraction was carried out by adding 600 micro
liter (µL) of acetonitrile to 200µL of plasma
containing Ciprofloxacin in a 5-mL glass
tube to precipitate protein and the tubes were
vortexed for 2 min. The samples were centrifuged at 4000 rpm for 10 min, and then the
upper organic phase was evaporated to dryness overnight in oven (memmert,
HongKong) set at 40°C. The residue was dissolved in 100 µL of the HPLC mobile phase,
in order to be injected into the HPLC system.
HPLC analysis: The plasma concentration
of Ciprofloxacin was determined using high
performance liquid chromatographic (HPLC)
procedure as described by Kordick and coauthors with some modifications (20).
The Breeze HPLC experimental conditions were optimized on stainless steel column 75 x 4.6 mm ID packed with base deactivated octadecylsilyl silica gel chromatography (5µm). The mobile phase used was a
mixture of 0.025 M phosphoric acid and acetonitrile (87:13).The pH of phosphoric acid
was adjusted with triethylamine to 3.0. The
flow rate used was 1.5 mL/min and the injection volume was 10 µL. The analyte was detected with a UV detector at wavelength 278
nm.
Calibration curve for Ciprofloxacin in
mobile phase, in the concentration range of
0.2 and 150 µg/mL, was constructed. Afterwards, the unknown plasma levels of ciprofloxacin were quantified by comparison of
ciprofloxacin peak area with a calibration
curve formula using Microsoft Office Excel
2007. The stock standard solution was prepared by adding 12.5 mg of ciprofloxacin
HCl, accurately weighed, to 25-ml volumetric flask, then adding 0.1 mL of 7% phosphoric acid.
Pharmacokinetic Analysis
The plasma concentration versus time
curve for each individual rabbit was fitted
using PKSolver- a freely available add-in
program for Microsoft Excel. Pharmacokinetic parameters were determined using non-

compartmental analysis. Peak plasma concentration (Cmax) and time to peak plasma
concentration (Tmax) values were obtained
from observed data on the Ciprofloxacin
plasma concentration – time curve for each
individual rabbit. Elimination or terminal rate
constant (k) was calculated from the terminal
portion of the plasma concentration – time
curve using least-square regression analysis
of the logarithm of concentration versus time.
Biological half-life (T1/2) was calculated
by the following relationship:
T1/2 = 0.693/k
The area under concentration curve
(AUC) was calculated by trapezoidal rule to
10 hours.
Statistical Analysis
Data management and analysis were performed using Microsoft Office Excel 2007.
Data from pharmacokinetic analysis are reported as mean ± SEM (n=4). Student`s t-test
was used to evaluate the significance of difference between the means of kinetic parameters obtained from the 2 groups. Pvalues <0.05 were considered significant.
RESULTS
The retention time for ciprofloxacin was
4 minutes with limit of detection (LOD) of
0.06 µg/mL and limit of quantification
(LOQ) of approximately 0.2 µg/mL.
The linearity of the calibration curve for
Ciprofloxacin
was
studied
at
the
concentration range of 0.2-150 µg/mL. The
standard curve showed a good linearity over
the range concentrations examined. The
equation that best described the relationship
between ciprofloxacin concentration levels
and response is shown as:
Abs = 0.0273 Conc. – 0.0709, R² = 0.9977
In vivo bioavailability study
The mean ± SD plasma concentration of
Ciprofloxacin versus time obtained following
oral administration of Ciprocare® half tablet
(125 mg) to 2 groups of rabbits are plotted in
figure 1.
The results show a significant effect of
Molokhia soup on the bioavailability of
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ciprofloxacin. The median Tmax was 1.5 hr
under fasting conditions compared to 2 hr
under fed condition. The geometric mean
value for Cmax was lower when ciprofloxacin
was co-administered with Molokhia soup.
Moreover, the AUC was significantly reduced after administration of Molokhia soup.

Figure (1): Plasma concentration of
Ciprofloxacin in rabbits with/ without
Molokai soup.
The pharmacokinetic parameters of
ciprofloxacin absorption in each group are
listed in Table 1 along with the statistical
significance values. The elimination half-life
of ciprofloxacin in rabbits was 3.05 hr. This
value for half-life is in accordance with previous studies (half-life 3-6 hour) (12-14).
Table (1): The pharmacokinetic parameters
for Ciprofloxacin HCl under fasted and fed
conditions.

T max (hr)
C max (µg/mL)
AUC
(µg.h/mL)

Treatment
Fasting
State
1.75 ± 0.288
0.792
±
0.286
2.642
±
0.488

Fed State
2.00 ± 0.707
0.452± 0.092
0.964
0.228

±

DISCUSSION
This study was conducted to determine
the effects of Molokhia soup on the rate and
extent of absorption of ciprofloxacin antibiotic in rabbits, and to provide explanations
for the observed effects of food.
Using the ratio of the means of AUC 0-10
and Cmax for Ciprocare® Tablets in fed and

fasting studies for the bioequivalence comparison, it was found that fed study had significantly lower bioavailability compared to
that in fasting study. The ratios for AUC-Fed/
AUC-Fasting and Cmax-Fed/ Cmax-Fasting were 0.36
and 0.57, respectively.
The ingestion of Molokhia soup has significant effect on the in vivo absorption of
Ciprofloxacin in rabbits. The maximum drug
concentration Cmax was significantly reduced
by the intake of molokhia soup by 30% compared to the fasted state (P value less than
0.05). The absolute bioavailability of ciprofloxacin was significantly lower when the
drug was co-administered with Molokhia
soup (43% reduction).
Ciprofloxacin was rapidly absorbed
when given orally as a solid dosage with a
Tmax of 1.75 h. Under fed conditions, Tmax
was prolonged compared with drug administration under fasted state (2 hr). However,
this effect was statistically insignificant with
P value greater than 0.05.The observed delay
in Tmax under fed state is in accordance with
previous reports, which demonstrated a prolonged Tmax under fed state.
Meal viscosity is one of the factors contributing to the undesirable food effects. C.
Olitorius leaves are rich in hydrocolloids and
mucilage, its viscosity was reported to surpass that of guar gum and locust been gum
under similar conditions. The high content of
these polysaccharides in plant leaves explain
the viscous consistency of this soup. The observed findings can be attributed to high viscosity of Molokhia soup, which may be another possible explanation for these observations, which is the formation of film layer on
surface of the tablet as a result of Molokhia
leaves precipitation on the tablet.
The observed undesirable food effects
may have significant clinical outcomes.
Molokhia ingestion can definitely decrease
ciprofloxacin levels in the blood and this may
lead to treatment failure and bacterial resistance. Therefore, ciprofloxacin is recommended to be administered on an empty
stomach at least one hr before or 2 hr after
Molokhia soup intake.
CONCLUSIONS
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In conclusion, the concomitant intake of
Molokhia soup with ciprofloxacin can significantly reduce drug bioavailability. In this
study, Molokhia soup caused a delay of the
in vivo absorption by approximately 30 minutes in healthy rabbits. Moreover, there was a
reduction in Cmax by about 30%. Food viscosity appears to be an important parameter affecting drugs absorption.
This kind of undesirable food effect may
lead to sub-therapeutic levels, treatment failure and bacterial resistance. Therefore, care
should be given to avoid administering
Ciprofloxacin with Molokhia soup and patients should be informed about such fooddrug interactions. Further studies are needed
to evaluate the effect of Palestinian food on
the bioavailability of the different drugs.
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